On Wednesday, December 21, 2005, the Senate will vote on the vaccine immunity amendment that was just passed by the House. This bill — Section 6 of S. 1873, the Biodefense and Pandemic Vaccine and Drug Development Act of 2005, sponsored by Senator Richard Burr, R-N.C. — would set a dangerous and unprecedented standard of care for drug manufacturers, allowing civil suits only when a drug company has engaged in willful misconduct. Although it is touted as a necessary measure to assure an effective response to the bird flu, in fact it would apply to untold numbers of drugs and would set a frightening precedent in reducing corporate accountability.
Immunity Sought as Avian Flu Shadow Approaches
Will Congress Give Vaccine Makers a Shot in the Arm?
Frist Inoculates Drug Makers For Any Vaccine Liability After Industry Won Him Senate
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.